Skip to main content
Equibles

FULLER & THALER ASSET MANAGEMENT, INC.

Position in EOLS — Evolus, Inc.

CIK 1082327 SAN MATEO, CA
Back to EOLS Full portfolio

Position in EOLS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$382,033
+$153,875 QoQ
Shares Held
55,048
-0.8% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 158 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 85% Shared 0% None 15%

Common Shares in EOLS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

FULLER & THALER ASSET MANAGEMENT, INC. holds $857,277,969 across 12 Drug Manufacturers - Specialty & Generic names. EOLS ranks #11 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INDV
Indivior Pharmaceuticals, Inc.
 4,615,816 $189,386,930
2 ELAN
Elanco Animal Health Inc
 6,240,240 $153,572,306
3 UTHR
UNITED THERAPEUTICS Corp
 220,697 $119,580,255
4 PBH
Prestige Consumer Healthcare Inc.
 2,331,821 $110,225,178
5 LQDA
Liquidia Corp
 1,209,604 $96,441,726
6 PRGO
PERRIGO Co plc
 7,498,227 $77,906,578
7 COLL
Collegium Pharmaceutical, Inc
 1,632,781 $59,106,672
8 NBIX
Neurocrine Biosciences Inc
 179,149 $30,193,772

All Filings in EOLS

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $382,033 55,048
2026-03-31 $228,158 55,513